Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kluth

Showing results (681-690 of 1,145) with videos related to

Pageof 115
Sort By:
World Journal of Urology|April 22, 2025
Endoscopic ablation versus nephroureterectomy in localized low-grade upper tract urothelial carcinoma: a comparison in terms of cancer-specific and other-cause mortalityCarolin Siech, Letizia Maria Ippolita Jannello, Mario de Angelis, et al.
Annals of Epidemiology|January 14, 2023
Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United StatesCristina Cano Garcia, Nancy Nimer, Mattia Luca Piccinelli, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
International Journal of Cancer|February 14, 2014
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancerMartina Kluth, Silvia Harasimowicz, Lia Burkhardt, et al.
International Urology and Nephrology|February 22, 2023
Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalitiesCristina Cano Garcia, Mattia Luca Piccinelli, Stefano Tappero, et al.
Clinical Genitourinary Cancer|August 15, 2024
Regional Differences in Stage III Nonseminoma Germ Cell Tumor Patients Across SEER RegistriesCristina Cano Garcia, Francesco Barletta, Stefano Tappero, et al.
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
European Urology Open Science|October 3, 2022
Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive NephrectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate CancersChristoph Burdelski, Michael Fitzner, Claudia Hube-Magg, et al.
Pageof 115

Showing results (681-690 of 1,145) with videos related to

Sort By:
Pageof 115
World Journal of Urology|April 22, 2025
Endoscopic ablation versus nephroureterectomy in localized low-grade upper tract urothelial carcinoma: a comparison in terms of cancer-specific and other-cause mortalityCarolin Siech, Letizia Maria Ippolita Jannello, Mario de Angelis, et al.
Annals of Epidemiology|January 14, 2023
Differences in overall survival between clear cell metastatic renal cell carcinoma patients versus population-based controls according to race/ethnicity in the United StatesCristina Cano Garcia, Nancy Nimer, Mattia Luca Piccinelli, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
International Journal of Cancer|February 14, 2014
Clinical significance of different types of p53 gene alteration in surgically treated prostate cancerMartina Kluth, Silvia Harasimowicz, Lia Burkhardt, et al.
International Urology and Nephrology|February 22, 2023
Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalitiesCristina Cano Garcia, Mattia Luca Piccinelli, Stefano Tappero, et al.
Clinical Genitourinary Cancer|August 15, 2024
Regional Differences in Stage III Nonseminoma Germ Cell Tumor Patients Across SEER RegistriesCristina Cano Garcia, Francesco Barletta, Stefano Tappero, et al.
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
European Urology Open Science|October 3, 2022
Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive NephrectomyBenedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate CancersChristoph Burdelski, Michael Fitzner, Claudia Hube-Magg, et al.
Pageof 115